Results 21 to 30 of about 395,596 (294)

Correction: Current evidence and emerging approaches in immunotherapy for gynecological cancers [PDF]

Discover Oncology
Victory Jesutoyosi Ashonibare, Oluwaseun Samuel Hezekiah, Omotola Seunfunmi Kukoyi, Suliat Adenike Hassan, Olaoluwa Ayoade Afolabi, Tunmise Maryanne Akhigbe, Roland Eghoghosoa Akhigbe   +6 more
doaj   +2 more sources

Radiosurgery for classical trigeminal neuralgia: impact of the shot size on clinical outcome

The Journal of Headache and Pain, 2023
Background This study compares the outcome of patients suffering from medically refractory classical trigeminal neuralgia (TN) after treatment with radiosurgery using two different shot sizes (5- and 6-mm).
Cécile Ortholan, Philippe Colin, Benjamin Serrano, Thibault Bouet, Nicolas Garnier, Maud le Guyader, Regis Amblard, Rémy Villeneuve, Stéphane Chanalet, Haiel Alchaar, Eric Bozzolo, Michel Lanteri-Minet, Denys Fontaine   +12 more
doaj   +1 more source

Grace upon Grace

Stellenbosch Theological Journal, 2021
Johan Cilliers relates that Grace upon Grace came to existence in his experience of "being retired of late", where he could "ponder the meaning of life from a different angle" (xi). On the one hand, Cilliers implies that Grace upon Grace does not have the purpose of academic contemplation.
openaire   +1 more source

Role of Apoptosis in HIV Pathogenesis

Advances in Virology, 2022
The apoptotic pathway is an important cell death pathway that contributes to the maintenance of homeostasis in living systems. However, variations in apoptosis have been linked to many diseases such as cancers and chronic infections.
Cyril Jabea Ekabe, Njinju Asaba Clinton, Eugene Kusi Agyei, Jules Kehbila   +3 more
doaj   +1 more source

Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?

Cellular & Molecular Biology Letters, 2017
Background Clinicians use clinical and pathological parameters, such as tumour size, grade and nodal status, to make decisions on adjuvant treatments for breast cancer.
Umar Wazir, Kinan Mokbel, Amtul Carmichael, Kefah Mokbel   +3 more
doaj   +1 more source

On the Graceful Game

CoRR, 2020
A graceful labeling of a graph $G$ with $m$ edges consists of labeling the vertices of $G$ with distinct integers from $0$ to $m$ such that, when each edge is assigned as induced label the absolute difference of the labels of its endpoints, all induced edge labels are distinct.
Luisa Frickes, Simone Dantas, Atílio G. Luiz   +2 more
openaire   +2 more sources

De-Escalation of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy

European Journal of Breast Health, 2022
Breast cancer treatment has seen many advances in recent decades, lessening the morbidity to patients, while improving outcomes. Central to these gains has been the introduction of breast conserving surgery and neoadjuvant systemic therapy (NST).
Umar Wazir, Kefah Mokbel
doaj   +1 more source

Is Autologous Fat Grafting an Oncologically Safe Procedure following Breast Conserving Surgery for Breast Cancer? A Comprehensive Review

Journal of Investigative Surgery, 2022
Background Autologous fat grafting (AFG) is a recognized surgical procedure to correct deformities following breast conservation surgery (BCS) for breast cancer. However, there are concerns about the oncological safety of this technique. In this study we
Salim Tayeh, Samantha Muktar, Umar Wazir, Amtul. R. Carmichael, Zuhair Al-Fardan, Abdul Kasem, Moustapha Hamdi, Kefah Mokbel   +7 more
doaj   +1 more source

Spontaneous Spinal Epidural Hematoma in a Patient on Apixaban for Nonvalvular Atrial Fibrillation

Case Reports in Hematology, 2020
Background. With the rise in the use of direct oral anticoagulants (DOACs), more hemorrhagic complications are being encountered. Since the first description of a case of spontaneous spinal epidural hematoma (SSEH) related to the utilization of DOACs in ...
Ahmad El Alayli, Logeswari Neelakandan, Hicham Krayem   +2 more
doaj   +1 more source

Preclinical pharmacology and safety studies to support an AAV9 NGLY1 gene therapy clinical trial for the treatment of NGLY1 deficiency

Molecular Therapy: Methods & Clinical Development
GS-100 is an AAV9 gene replacement therapy for the treatment of N-glycanase 1 (NGLY1) deficiency, an ultra-rare, recessive disorder characterized by developmental delay, intellectual disability, hyperkinetic movement disorder, elevated liver enzymes ...
Lei Zhu, Jennifer W. Cook, Alicia Newton, Selina S. Dwight, Brendan Beahm, Matt Wilsey, William F. Mueller, Becky Schweighardt   +7 more
doaj   +1 more source